Related Experiment Video
Updated: May 1, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Adaptive Radiation Therapy in Lymphomas: Indications, Early Experiences, and Future Directions
Kiran A Kumar1, Xinran Zhong1, Zohaib Iqbal1
1Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
Adaptive radiation therapy (ART) improves tumor targeting and reduces treatment volume in lymphoma patients. This technique allows for safer, shorter radiation courses, even in challenging cases.
Area of Science:
- Radiation Oncology
- Medical Physics
- Hematology Oncology
Background:
- Lymphomas are radiosensitive and can present in difficult-to-target locations.
- Adaptive radiation therapy (ART) offers potential benefits by allowing for smaller treatment volumes and adaptation to tumor shrinkage.
Purpose of the Study:
- To hypothesize that ART may be beneficial in various lymphoma cases.
- To describe early experiences and outline indications for ART in lymphomas.
Main Methods:
- A prospective registry of lymphoma patients treated with online adaptive RT (oART) using cone-beam CT was reviewed.
- Patients were categorized by lymphoma type, and reasons for adaptation were analyzed.
Main Results:
- Seventy-two treatment courses from 67 patients (26 low-grade, 46 high-grade lymphomas) were analyzed.
- Primary indications for oART included better targeting in mobile locations (69%), changing gross disease (69%), and hypofractionation (38%).
- oART improved planning target volume (PTV) coverage from 72.2% to 95.2% and reduced PTV size by 24.6% in cases with gross disease.
Conclusions:
- Online adaptive RT can be successfully implemented in diverse lymphoma cases.
- oART reduces treatment volume while maintaining PTV coverage, enabling safer and shorter radiation courses.
- Further studies are needed to confirm the clinical benefits of oART in lymphomas.
More Related Videos
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy